U.S. reveals rapid rollout plan for vaccine after record coronavirus surge
"Within 24 hours, maybe at most 36 to 48 hours, from the approval, the vaccine can be in people's arms," Moncef Slaoui, a former GlaxoSmithKline executive, said at an event conducted by The Washington Post newspaper.